BRPI0513237A - hidrolisados de proteìna para diminuição de pressão sanguìnea - Google Patents

hidrolisados de proteìna para diminuição de pressão sanguìnea

Info

Publication number
BRPI0513237A
BRPI0513237A BRPI0513237-1A BRPI0513237A BRPI0513237A BR PI0513237 A BRPI0513237 A BR PI0513237A BR PI0513237 A BRPI0513237 A BR PI0513237A BR PI0513237 A BRPI0513237 A BR PI0513237A
Authority
BR
Brazil
Prior art keywords
blood pressure
protein hydrolysates
lowering blood
protein
ipp
Prior art date
Application number
BRPI0513237-1A
Other languages
English (en)
Inventor
Luppo Edens
Andre Leonardus De Roos
Robertus Antonius Mijnd Hoeven
Philippus Antonius Deen
Original Assignee
Dsm Assets B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Assets B V filed Critical Dsm Assets B V
Publication of BRPI0513237A publication Critical patent/BRPI0513237A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

HIDROLISADOS DE PROTEìNA PARA DIMINUIçãO DE PRESSãO SANGUìNEA A presente invenção descreve um processo para produzir IPP a partir de uma fonte de proteína, pelo que a proporção de IPP e VPP produzidos pela proteína é de pelo menos 5, de preferência pelo menos 10 e mais preferivelmente pelo menos 20, o qual compreende o uso de uma endoprotease prolina específica.
BRPI0513237-1A 2004-07-12 2005-07-12 hidrolisados de proteìna para diminuição de pressão sanguìnea BRPI0513237A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04077015 2004-07-12
EP04103593 2004-07-27
EP04106859 2004-12-22
PCT/EP2005/053336 WO2006005757A2 (en) 2004-07-12 2005-07-12 Blood pressure lowering oligopeptides

Publications (1)

Publication Number Publication Date
BRPI0513237A true BRPI0513237A (pt) 2008-04-29

Family

ID=35784222

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513237-1A BRPI0513237A (pt) 2004-07-12 2005-07-12 hidrolisados de proteìna para diminuição de pressão sanguìnea

Country Status (9)

Country Link
US (1) US20070207944A1 (pt)
EP (1) EP1774014A2 (pt)
JP (1) JP2008505653A (pt)
AU (1) AU2005261652A1 (pt)
BR (1) BRPI0513237A (pt)
CA (1) CA2569926A1 (pt)
EA (1) EA011865B1 (pt)
NZ (1) NZ552140A (pt)
WO (1) WO2006005757A2 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004098309A1 (en) 2003-05-05 2004-11-18 Unilever N.V. Hydrolysed casein product comprising tripeptides ipp and/ or vpp
WO2005027953A2 (en) * 2003-09-23 2005-03-31 Dsm Ip Assets B.V. Use of proline specific endoproteases to hydrolyse peptides and proteins
CN101084004A (zh) * 2004-12-22 2007-12-05 帝斯曼知识产权资产管理有限公司 单个酶促步骤中的血压降低寡肽
DK1831361T3 (da) 2004-12-23 2012-05-14 Campina Nederland Holding Bv Proteinhydrolysat beriget med peptider, som inhiberer DPP-IV, og deres anvendelse
JP4732112B2 (ja) * 2005-01-20 2011-07-27 サッポロビール株式会社 発泡アルコール飲料の製造方法及びその方法を用いて製造された発泡アルコール飲料
JP5770411B2 (ja) 2005-02-24 2015-08-26 ディーエスエム アイピー アセッツ ビー．ブイ． グリコマクロペプチド由来の血圧降下ペプチド
ZA200709009B (en) * 2005-04-28 2009-01-28 Unilever Plc Peptides having an ace inhibiting effect
TW200803751A (en) 2005-11-30 2008-01-16 Campina Nederland Holding Bv Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1
CN101511211A (zh) * 2006-02-02 2009-08-19 帝斯曼知识产权资产管理有限公司 包含脯氨酸特异性蛋白酶的食物产品
KR101048663B1 (ko) * 2006-02-14 2011-07-12 칼피스가부시키가이샤 동맥경화 예방제, 혈관 내막의 비후 억제제 및 혈관 내피 기능 개선제
AU2006343802A1 (en) 2006-05-15 2007-11-22 Valio Ltd New use of therapeutically useful peptides
TWI414305B (zh) * 2007-03-27 2013-11-11 Calpis Co Ltd 腎衰竭預防劑
WO2008123095A1 (ja) 2007-03-27 2008-10-16 Calpis Co., Ltd. 心不全予防剤
JP5736533B2 (ja) * 2007-07-19 2015-06-17 学校法人北里研究所 抗ストレス作用と嗜好性向上効果を備えたペプチド性ペットフード素材
CN101925674A (zh) * 2007-11-23 2010-12-22 帝斯曼知识产权资产管理有限公司 改进的生物活性肽生产
WO2010046298A2 (en) * 2008-10-21 2010-04-29 Dsm Ip Assets B.V. Improved peptide availability
JP2011136932A (ja) * 2009-12-28 2011-07-14 Calpis Co Ltd 脳機能改善用組成物および脳機能を改善する方法
NO20100359A1 (no) 2010-03-08 2011-09-09 Marine Bioproducts As Peptidmateriale og preparater og anvendelser derav.
NO20100370A1 (no) 2010-03-08 2011-09-09 Marine Bioproducts As Peptidmateriale, fôrsammensetninger og preparater, og anvendelser derav.
NO20100369A1 (no) 2010-03-08 2011-09-09 Marine Bioproducts As Peptidmateriale, fôrsammensetning og preparater og anvendelser derav.
JP5718741B2 (ja) * 2011-06-24 2015-05-13 カルピス株式会社 脳機能改善用ペプチドの酵素的製造方法
CN103204909B (zh) * 2013-04-17 2014-09-03 苏州凯祥生物科技有限公司 一种抗高血压活性肽vppipp
US9530146B2 (en) * 2013-09-05 2016-12-27 Dsm Ip Assets B.V. Marketing the use of an acidic soft drink to enhance the efficacy of a gluten-digesting enzyme
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
US11918007B2 (en) * 2017-12-14 2024-03-05 Universidade Do Porto Foodstuff composition comprising a derivate of olive pomace

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486461A (en) * 1991-11-08 1996-01-23 Novo Nordisk A/S Casein hydrolyzate and method for production of such casein hydrolyzate
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
JP4633876B2 (ja) * 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
AU2001255501A1 (en) * 2000-04-21 2001-11-07 Monsanto Technology Llc Blood-pressure reducing polypeptides containing vpp derived from microorganisms
ATE372689T1 (de) * 2001-07-18 2007-09-15 Dsm Ip Assets Bv Verfahren zur hydrolyse von milcheiweissen
WO2004098309A1 (en) * 2003-05-05 2004-11-18 Unilever N.V. Hydrolysed casein product comprising tripeptides ipp and/ or vpp

Also Published As

Publication number Publication date
JP2008505653A (ja) 2008-02-28
US20070207944A1 (en) 2007-09-06
EA200700215A1 (ru) 2007-06-29
EP1774014A2 (en) 2007-04-18
AU2005261652A1 (en) 2006-01-19
EA011865B1 (ru) 2009-06-30
CA2569926A1 (en) 2006-01-19
NZ552140A (en) 2009-02-28
WO2006005757A3 (en) 2007-03-15
WO2006005757A2 (en) 2006-01-19

Similar Documents

Publication Publication Date Title
BRPI0513237A (pt) hidrolisados de proteìna para diminuição de pressão sanguìnea
BRPI0519496A2 (pt) processo para preparar um composto ou uma composiÇço, e, composiÇço
AR050254A1 (es) Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas
BRPI0408881A (pt) composição adoçante de alta intensidade e suprimento da mesma
BR0308211A (pt) Cumarinas úteis como biomarcadores
DE602006006200D1 (de) Antikörper gegen 25-hydroxyvitamin d
BRPI0314814B8 (pt) anticorpo compreendendo uma variante de fc
BRPI0515940A (pt) membro linear
BR0305842A (pt) Mistura curável, e, método
BR0309575A (pt) Processo para a preparação de uma solução aquosa de acrilato de metal alcalino, e, uso de uma solução aquosa de acrilato de metal alcalino
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
BR0211293B1 (pt) processo para produzir continuamente uma composição elastomérica.
BR0311242A (pt) Processo para preparar modafinil
BRPI0911907B8 (pt) processo para produzir uma composição contendo triptofano e composição proteica contendo triptofano
BRPI0417992A (pt) método para purificar fsh
BRPI0517824A (pt) processo para a sìntese de zeólita beta com dietilenotriamina
MXPA03004986A (es) Proceso para preparar polimeros de emulsion con alta pureza.
BRPI0608273A2 (pt) peptìdeos para diminuição da pressão sanguìnea a partir de glicomacropeptìdeo
BRPI0404824A (pt) Processos para preparar uma composição de polìmero, um polìmero multifuncional, e uma composição multifuncional para modificação de cabelos
BRPI0605833A (pt) pregabalina livre de ácido isobutilglutárico e um processo para sua preparação
BRPI0417360A (pt) método para a preparação de multiparticulados farmacêuticos
BRPI0600167A (pt) processo para destilação de uma mistura de diisocianato-difenilimetanos isoméricos
AR064219A1 (es) Cuerpo moldeado que contiene titanio
BR112015008661A2 (pt) processos de separação para proteína de soja

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.